{
  "decision_id": "RGDS-DEC-0005",
  "decision_title": "Conditional-Go \u2014 Draft Module 2.6 at Risk Pending Final Study Report (Kasturi pattern)",
  "program_context": {
    "program_id": "PRG-245",
    "asset_or_initiative": "ABC-101",
    "domain": "regulatory_ops",
    "target_product_profile": {
      "intended_indication": "Oncology (solid tumors)",
      "patient_population": "Adults with advanced disease",
      "route_of_administration": "IV",
      "dosing_regimen": "Q3W",
      "key_safety_considerations": [
        "First-in-human dose justification",
        "Nonclinical safety margins"
      ],
      "development_stage_relevance": "IND compilation (Module 2 summaries pending final nonclinical reports)"
    }
  },
  "status": "decided",
  "created_at": "2025-12-27T13:30:00-05:00",
  "created_by": {
    "name": "Mark Banasihan",
    "role": "Principal AI Business Analyst (Case Study)"
  },
  "gate": {
    "gate_name": "Module 2 Draft Readiness",
    "gate_type": "phase_gate",
    "gate_date": "2026-01-12",
    "decision_deadline": "2026-01-10T17:00:00-05:00",
    "meeting_refs": [
      "CONFL-1120",
      "GCAL-210"
    ]
  },
  "decision_question": "Can we proceed with Draft 1 of Module 2.6 using controlled placeholders for the pending Study-07 final report, with explicit verification, review routing, and a contingency plan if the report is late or changes materially?",
  "options_considered": [
    {
      "option_id": "A",
      "description": "Proceed with Draft 1 using placeholders for Study-07; lock verification and triage review routing.",
      "pros": [
        "Preserves submission-critical writing timeline",
        "Makes risk explicit and bounded"
      ],
      "cons": [
        "Requires disciplined closure workflow",
        "Late changes may compress review"
      ],
      "estimated_impact": "On-time Draft 1; manageable residual risk if conditions and routing are enforced."
    },
    {
      "option_id": "B",
      "description": "Wait for Study-07 final report before drafting Module 2.6.",
      "pros": [
        "Avoids placeholder risk",
        "Simplifies final reconciliation"
      ],
      "cons": [
        "Likely slips Draft 1 and compresses downstream review cycles",
        "Increases end-of-cycle congestion"
      ],
      "estimated_impact": "Higher immediate certainty; higher schedule risk."
    }
  ],
  "decision_outcome": {
    "outcome": "conditional_go",
    "selected_option_id": "A",
    "conditions": [
      {
        "condition": "Receive Study-07 final report (QA released) and reconcile all placeholder text/values in Module 2.6 within 24 hours.",
        "owner": {
          "name": "Medical Writer Lead",
          "role": "Regulatory Medical Writing"
        },
        "due_date": "2026-01-09",
        "evidence_to_close": "Study-07 final report + reconciliation memo + updated Module 2.6 draft stored in controlled location"
      },
      {
        "condition": "Run consistency check across Module 2.6 and referenced tables/appendices; log discrepancies and resolution.",
        "owner": {
          "name": "QA Representative",
          "role": "Quality"
        },
        "due_date": "2026-01-10",
        "evidence_to_close": "Consistency check checklist + discrepancy log with signed resolution"
      }
    ],
    "rationale_summary": "Drafting Module 2.6 now preserves the IND timeline while acknowledging a known rate-limiting input (Study-07 final report). The risk is acceptable because placeholders are limited in scope, verification criteria are explicit, reviewer routing is pre-defined for late changes, and a contingency plan is in place if the report is delayed or materially different from preliminary outputs."
  },
  "risk_posture": {
    "program_risk_tolerance": "medium",
    "regulatory_risk_tolerance": "low",
    "justification": "Regulatory-facing summaries must be consistent and traceable; drafting at risk is acceptable only with strict verification and fast reconciliation once the final report is available.",
    "known_unknowns": [
      "Final QA release timing for Study-07",
      "Magnitude of deltas between preliminary outputs and final report"
    ],
    "tradeoffs": [
      "Accept controlled placeholder drafting to protect schedule while increasing review routing overhead near the deadline."
    ]
  },
  "author_at_risk_items": [
    {
      "artifact": "Module 2.6 (Nonclinical Written and Tabulated Summaries)",
      "placeholder_type": "missing_report",
      "verification_source": "Study-07 final report (QA released) + appendix tables",
      "acceptance_criteria": "All placeholders replaced; values and narratives match the final report; traceability links updated; no unresolved discrepancies remain.",
      "deadline": "2026-01-09",
      "owner": {
        "name": "Medical Writer Lead",
        "role": "Regulatory Medical Writing"
      },
      "fallback_plan": "If the Study-07 final report is not received by the deadline, escalate to decision_owner and switch to a defer-with-required-evidence posture for Module 2.6 finalization; submit Draft 1 with placeholders clearly flagged and restrict downstream dependencies until closure."
    }
  ],
  "review_plan": {
    "required_reviewers": [
      {
        "name": "Nonclinical Lead",
        "role": "Toxicology"
      },
      {
        "name": "QA Representative",
        "role": "Quality"
      },
      {
        "name": "Regulatory Lead",
        "role": "Regulatory Strategy"
      }
    ],
    "optional_reviewers": [
      {
        "name": "Program Manager",
        "role": "Regulatory Operations"
      },
      {
        "name": "Biostats Partner",
        "role": "Statistics"
      }
    ],
    "rationale": "Late-breaking changes from Study-07 impact regulatory-facing summaries; required reviewers cover scientific accuracy, quality consistency, and regulatory positioning.",
    "timebox_hours": 24,
    "escalation_path": "If required reviewers do not respond within 24 hours, escalate to decision_owner for delegated authority signoff; document rationale in audit change log."
  },
  "scope_change_events": [
    {
      "date": "2025-12-26",
      "trigger": "late_report",
      "description": "Sponsor notified the team that Study-07 final report QA release will occur after Draft 1 kickoff.",
      "impact": [
        "timeline",
        "review_load",
        "drafting_at_risk"
      ],
      "decision_needed_by": "2025-12-27T17:00:00-05:00",
      "owner": {
        "name": "Program Manager",
        "role": "Regulatory Operations"
      },
      "resolution": "accepted",
      "notes": "Accepted with explicit author-at-risk controls and triage review routing."
    }
  ],
  "fallback_plan": {
    "trigger": "Study-07 final report not received by 2026-01-09 or material deltas require rework beyond the 24-hour review window.",
    "actions": [
      "Escalate to decision_owner and convene a same-day triage with required reviewers.",
      "Freeze downstream documents that depend on the affected summaries until reconciliation is approved.",
      "If timeline risk is critical, re-baseline submission plan and log a change request; document rationale for any residual placeholder content."
    ],
    "owner": {
      "name": "Decision Owner",
      "role": "Regulatory Program Lead"
    },
    "time_cost_estimate": "1\u20135 days depending on delta severity; may require change request and schedule re-baseline."
  },
  "evidence": {
    "evidence_items": [
      {
        "evidence_id": "E-101",
        "type": "memo",
        "title": "Drafting-at-risk plan for Module 2.6 (placeholder controls)",
        "source_system": "Confluence",
        "location_ref": "CONFL-1120",
        "owner": {
          "name": "Program Manager",
          "role": "Regulatory Operations"
        },
        "as_of": "2025-12-27T11:00:00-05:00",
        "relevance": "primary",
        "quality_notes": "Reviewed by Regulatory and QA for control completeness.",
        "confidence": "high"
      },
      {
        "evidence_id": "E-102",
        "type": "report",
        "title": "Study-07 preliminary output package (non-QA)",
        "source_system": "SharePoint",
        "location_ref": "SP://working/ABC-101/nonclinical/study07/prelim_v1.pdf",
        "owner": {
          "name": "Nonclinical Lead",
          "role": "Toxicology"
        },
        "as_of": "2025-12-24T09:00:00-05:00",
        "relevance": "supporting",
        "quality_notes": "Preliminary outputs; may change upon QA release.",
        "confidence": "medium"
      }
    ]
  },
  "known_gaps_and_assumptions": {
    "gaps": [
      {
        "gap": "Study-07 final QA-released report is not available at Draft 1 kickoff.",
        "impact": "Placeholders required; late deltas could compress review time.",
        "mitigation_plan": "Use author_at_risk_items controls; enforce 24-hour reconciliation + review plan; fallback_plan if missed."
      }
    ],
    "assumptions": [
      {
        "assumption": "Preliminary Study-07 outputs will not materially change upon QA release.",
        "risk_if_wrong": "Module 2.6 summaries may require rework and re-review.",
        "how_to_verify": "Compare preliminary outputs to final report; log deltas and obtain required reviewer signoff."
      }
    ]
  },
  "risk_assessment": {
    "key_risks": [
      {
        "risk": "Late Study-07 final report triggers compressed review and potential inconsistency.",
        "severity": "high",
        "likelihood": "possible",
        "detectability": "moderate",
        "mitigation": "Pre-define review routing and reconciliation timebox; escalate if missed.",
        "owner": {
          "name": "Program Manager",
          "role": "Regulatory Operations"
        }
      }
    ],
    "residual_risk_statement": "Residual risk is acceptable only if reconciliation and required reviews occur within the defined timebox; otherwise decision must be revisited.",
    "risk_acceptance_required": true
  },
  "governance": {
    "decision_owner": {
      "name": "Decision Owner",
      "role": "Regulatory Program Lead"
    },
    "approvers": [
      {
        "name": "Regulatory Lead",
        "role": "Regulatory Strategy"
      }
    ],
    "reviewers": [
      {
        "name": "Nonclinical Lead",
        "role": "Toxicology"
      },
      {
        "name": "QA Representative",
        "role": "Quality"
      }
    ],
    "approval_method": "meeting_vote",
    "approvals": [
      {
        "person": {
          "name": "Regulatory Lead",
          "role": "Regulatory Strategy"
        },
        "decision": "approve",
        "timestamp": "2025-12-27T13:20:00-05:00",
        "comments": "Proceed with controlled placeholders; enforce reconciliation and triage routing."
      }
    ],
    "final_signoff": {
      "person": {
        "name": "Decision Owner",
        "role": "Regulatory Program Lead"
      },
      "timestamp": "2025-12-27T13:30:00-05:00",
      "notes": "Conditional-go approved with explicit author-at-risk and fallback controls."
    }
  },
  "ai_assistance": {
    "used": false,
    "use_cases": [],
    "artifacts": [],
    "controls": {
      "prompt_or_instruction_ref": "",
      "schema_or_format_constraints": "",
      "versioning": "",
      "safety_notes": ""
    }
  },
  "actions": [
    {
      "action_id": "A-501",
      "description": "Create placeholder reconciliation checklist for Module 2.6.",
      "owner": {
        "name": "QA Representative",
        "role": "Quality"
      },
      "due_date": "2025-12-30",
      "status": "open",
      "success_criteria": ""
    }
  ],
  "dependencies": [
    "Module 4 study reports (Study-07 final report)",
    "Module 2.6 narrative summaries"
  ],
  "change_control": {
    "change_requests": [
      "CR-IND-011"
    ],
    "release_or_validation_refs": []
  },
  "audit": {
    "record_version": 1,
    "change_log": [
      {
        "version": 1,
        "changed_by": {
          "name": "Mark Banasihan",
          "role": "Principal AI Business Analyst (Case Study)"
        },
        "changed_at": "2025-12-27T13:35:00-05:00",
        "summary": "Created decision record with author-at-risk controls and fallback plan (v1.2 additions)."
      }
    ],
    "supersedes": null,
    "superseded_by": null,
    "retention_class": "controlled_record"
  },
  "decision_category": "internal"
}